Sleep Disorders Trial, Recruiting NCT06580561 Sponsor: University of Michigan Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06580561
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A doctor has diagnosed the person with knee osteoarthritis (this can be self-reported)
  • The person experiences ongoing knee pain that is at least moderate in intensity
  • The person has ongoing sleep problems consistent with insomnia, based on a specific sleep questionnaire score
  • If the person takes medication for pain or sleep, their prescription has not changed in the past three months, and they are willing to keep medications the same throughout the study
  • The person has a sufficient reading level to complete online surveys independently, assessed using a short three-question screener

Who may not be able to join:

  • The person has also been diagnosed with a condition where the immune system attacks the joints, such as rheumatoid arthritis
  • The person has an active cancer diagnosis
  • The person has a neurological condition, such as a movement disorder
  • A doctor or healthcare professional has advised the person to avoid physical activity for any reason
  • The person does not understand English well enough to take part in the program
  • The person is unable to give consent electronically
  • The person shows signs of significant memory or thinking difficulties, based on a short cognitive screening test
  • The person has a severe mental health condition
  • The person is currently taking part in, or has taken part in the past six months in, another clinical trial or a pain or sleep management program
  • The person has a vision or hearing impairment that would prevent them from using the program
  • The person has a serious physical health condition that requires surgery, or has a life expectancy of less than six months
  • The person has an irregular sleep schedule, such as shift work
  • The person has been diagnosed with a sleep disorder other than insomnia — such as sleep apnea or narcolepsy — that is not currently well managed
  • The person already meets or exceeds the physical activity guidelines set by the U.S. Department of Health and Human Services (confirm specific thresholds with the trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Whibley, PhD, University of Michigan

Phone: 734-936-2844

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 November 2024
Est. completion
29 February 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in average pain intensity using a 0-10 numerical rating scale between baseline and the 8-week follow-up (post-intervention) period

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov